Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects

Background: The influenza B virus has two lineages; Yamagata and Victoria. The two lineages are antigenically distinct and it is difficult to expect cross-protection between the lineages. Actually, the mismatch between circulating influenza B viruses and vaccine strains has been occurred frequently....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Choi, Won Suk, Noh, Ji Yun, Song, Joon Young, Cheong, Hee Jin, Wie, Seong-Heon, Lee, Jin Soo, Lee, Jacob, Kim, Shin-Woo, Jeong, Hye Won, Jung, Sook-In, Kim, Yeon-Sook, Woo, Heung Jeong, Kim, Kyung Ho, Kim, Hun, Kim, Woo Joo
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512784/
https://ncbi.nlm.nih.gov/pubmed/28406746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1297351
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars